SCHEMBL4622889

SCHEMBL4622889

N#Cc1ccc(OCCCN2CCC3CCCCC3C2)cc1

nearest known ligand 0.65

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 15/20 0.65
HRH2 P25021 12/20 0.65
HRH1 P35367 12/20 0.65
MEN1 O00255 5/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4685035 0.96 HRH3 (0.64) HRH3HRH2HRH1MEN1
Oxalic Acid SCHEMBL4491231 0.93 HRH3 (0.61) HRH3HRH2HRH1MEN1
SCHEMBL4494406 0.92 HRH3 (0.68) HRH3HRH2HRH1MEN1
Oxalic Acid SCHEMBL4505073 0.90 HRH3 (0.57) HRH3HRH2HRH1MEN1
SCHEMBL14150224 0.89 HRH3 (0.68) HRH3HRH2HRH1MEN1
SCHEMBL4491586 0.89 HRH3 (0.68) HRH3HRH2HRH1MEN1
SCHEMBL1978291 0.86 HRH3 (0.71) HRH3HRH2HRH1
SCHEMBL4684886 0.85 HRH3 (0.66) HRH3HRH2HRH1MEN1
Oxalic Acid SCHEMBL4495484 0.85 HRH3 (0.61) HRH3HRH2HRH1MEN1
Oxalic Acid SCHEMBL4500933 0.82 HRH3 (0.65) HRH3HRH2HRH1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317445-A2 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS ANORMED INC. (CA) 2003-06-11 EP claimed
WO-2002022600-A2 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS ANORMED INC. (CA) 2002-03-21 WO claimed
EP-4308694-A1 DOSING REGIMENS FOR HEMATOPOIETIC STEM CELL MOBILIZATION FOR STEM CELL TRANSPLANTS IN MULTIPLE MYELOMA PATIENTS Magenta Therapeutics, Inc. (US) 2024-01-24 EP disclosed
EP-4143302-A1 METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO Magenta Therapeutics, Inc. (US) 2023-03-08 EP disclosed
WO-2021222313-A1 METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO Magenta Therapeutics, Inc. (US) 2021-11-04 WO disclosed
EP-3720494-A2 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS Magenta Therapeutics, Inc. (US) 2020-10-14 EP disclosed
WO-2019113375-A2 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS Magenta Therapeutics, Inc. (US) 2019-06-13 WO disclosed
CN-101230033-B New azabicycloalkane derivatives, preparing method and medicament combination containing the same SERVIER LAB 2011-03-09 CN disclosed
CN-101230033-A New azabicycloalkane derivatives, preparing method and medicament combination containing the same SERVIER LAB (FR) 2008-07-30 CN disclosed
EP-1631307-A4 METHODS TO MOBILIZE PROGENITOR/STEM CELLS ANORMED INC (CA) 2008-03-26 EP disclosed
EP-1720544-B1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2008-03-19 EP disclosed
EP-1720544-A1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Les Laboratoires Servier (FR) 2006-11-15 EP disclosed
EP-1631307-A1 METHODS TO MOBILIZE PROGENITOR/STEM CELLS ANORMED INC. (CA) 2006-03-08 EP disclosed
WO-2005089747-A1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2005-09-29 WO disclosed
WO-2005000333-A1 METHODS TO MOBILIZE PROGENITOR/STEM CELLS ANORMED INC. (CA) 2005-01-06 WO disclosed